Pharmacological induction of tolerogenic dendritic cells and regulatory T cells

Seminars in Immunology

Volumn 16, Issue 2, 2004, Pages 127-134

  Adorini, Luciano ^a   Giarratana, Nadia ^a   Penna, Giuseppe ^a  

^a BioXell SpA   (Italy)

Author keywords

Pharmacological induction; Regulatory T cell; Tolerogenic dentritic cell; Vitamin D3 analogs

Indexed keywords

15 DEOXYSPERGUALIN; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; BUTYRIC ACID; CALCINEURIN INHIBITOR; COLECALCIFEROL DERIVATIVE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ALLOTYPE SUPPRESSION; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOSTIMULATION; IN VIVO STUDY; NONHUMAN; RECEPTOR UPREGULATION; REVIEW; T LYMPHOCYTE;

EID: 1242295281     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2003.12.008     Document Type: Article

References (66)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J.et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
2. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:2003;685-711.
3. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
4. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:2002;389-400.
5. Allison A.C. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology. 47:2000;63-83.
6. Vieira P.L., Kalinski P., Wierenga E.A., Kapsenberg M.L., de Jong E.C. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 161:1998;5245-5251.
7. Matasic R., Dietz A.B., Vuk-Pavlovic S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J. Leukoc. Biol. 66:1999;909-914.
8. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E.et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162:1999;6473-6481.
9. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R., van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30:2000;1807-1812.
10. Mehling A., Grabbe S., Voskort M., Schwarz T., Luger T.A., Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol. 165:2000;2374-2381.
11. Colic M., Stojic-Vukanic Z., Pavlovic B., Jandric D., Stefanoska I. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin. Exp. Immunol. 134:2003;63-69.
12. Woltman A.M., de Fijter J.W., Kamerling S.W., van Der Kooij S.W., Paul L.C., Daha M.R.et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood. 98:2001;174-180.
13. Hackstein H., Taner T., Zahorchak A.F., Morelli A.E., Logar A.J., Gessner A.et al. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood. 101:2003;4457-4463.
14. Lee J.I., Ganster R.W., Geller D.A., Burckart G.J., Thomson A.W., Lu L. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation. 68:1999;1255-1263.
15. Szabo G., Gavala C., Mandrekar P. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J. Investig. Med. 49:2001;442-449.
16. Contreras J.L., Wang P.X., Eckhoff D.E., Lobashevsky A.L., Asiedu C., Frenette L.et al. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation. 65:1998;1159-1169.
17. Thomas J.M., Contreras J.L., Jiang X.L., Eckhoff D.E., Wang P.X., Hubbard W.J.et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation. 68:1999;1660-1673.
18. Thomas J.M., Hubbard W.J., Sooudi S.K., Thomas F.T. STEALTH matters: a novel paradigm of durable primate allograft tolerance. Immunol. Rev. 183:2001;223-233.
19. Matasic R., Dietz A.B., Vuk-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology. 101:2000;53-60.
20. Hackstein H., Morelli A.E., Larregina A.T., Ganster R.W., Papworth G.D., Logar A.J.et al. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J. Immunol. 166:2001;7053-7062.
21. Millard A.L., Mertes P.M., Ittelet D., Villard F., Jeannesson P., Bernard J. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cell and macrophages. Clin. Exp. Immunol. 130:2002;245-255.
22. Verhasselt V., Vanden Berghe W., Vanderheyde N., Willems F., Haegeman G., Goldman M. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-κB inhibition. J. Immunol. 162:1999;2569-2574.
23. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D.et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:1995;531-536.
24. O'Sullivan B.J., MacDonald K.P., Pettit A.R., Thomas R. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11421-11426.
25. Martin E., O'Sullivan B., Low P., Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity. 18:2003;155-167.
26. Adorini L. Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases. Cell Mol. Life Sci. 55:1999;1610-1625.
27. Lechler R., Ng W.F., Steinman R.M. Dendritic cells in transplantation-friend or foe? Immunity. 14:2001;357-368.
28. Deluca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 15:2001;2579-2585.
29. Mathieu C., Adorini L. The coming of age of 1,25-dihydroxyVitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med. 8:2002;174-179.
30. Adorini L. Immunomodulatory effects of Vitamin D receptor ligands in autoimmune diseases. Int. Immunopharmacol. 2:2002;1017-1028.
31. Adorini L. 1,25-DihydroxyVitamin D3 analogs as potential therapies in transplantation. Curr. Opin. Investig. Drugs. 3:2002;1458-1463.
32. Griffin MD, Xing N, Kumar R. Vitamin D and its Analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 2003.
33. Carlberg C., Polly P. Gene regulation by Vitamin D3. Crit. Rev. Eukaryot. Gene Expr. 8:1998;19-42.
34. Penna G., Adorini L. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2000;2405-2411.
35. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E. et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164:2000;4443-4451.
36. Griffin M.D., Lutz W.H., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Potent inhibition of dendritic cell differentiation and maturation by Vitamin D analogs. Biochem. Biophys. Res. Commun. 270:2000;701-708.
37. Berer A., Stockl J., Majdic O., Wagner T., Kollars M., Lechner K.et al. 1,25-DihydroxyVitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 28:2000;575-583.
38. 3) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145:2001;351-357.
39. van Halteren A.G., van Etten E., de Jong E.C., Bouillon R., Roep B.O., Mathieu C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyVitamin D(3). Diabetes. 51:2002;2119-2125.
40. Hewison M., Freeman L., Hughes S.V., Evans K.N., Bland R., Eliopoulos A.G.et al. Differential regulation of Vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170:2003;5382-5390.
41. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyVitamin D3 and its analogs: a Vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 22:2001;22.
42. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:2001;1945-1953.
43. Gregori G., Giarratana N., Smiroldo S., Uskokovic M., Adorini L. A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes. 51:2002;1367-1374.
44. Allison A.C., Eugui E.M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin. Transplant. 10:1996;77-84.
45. Lu L., Thomson A.W. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation. 73:2002;S19-S22.
46. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238.
47. Alroy I., Towers T., Freedman L. Transcriptional repression of the interleukin-2 gene by Vitamin D3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell Biol. 15:1995;5789-5799.
48. Takeuchi A., Reddy G., Kobayashi T., Okano T., Park J., Sharma S. Nuclear factor of activated T cells (NFAT) as a molecular target for 1α,25-dihydroxyVitamin D3-mediated effects. J. Immunol. 160:1998;209-218.
49. Cippitelli M., Santoni A. Vitamin D3: a transcriptional modulator of the IFN-γ gene. Eur. J. Immunol. 28:1998;3017-3030.
50. D'Ambrosio D., Sinigaglia F., Adorini L. Special attractions for suppressor T cells. Trends Immunol. 24:2003;122-126.
51. Penna G., Vulcano M., Roncari A., Facchetti F., Sozzani S., Adorini L. Differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 169:2002;6673-6676.
52. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:2002;151-161.
53. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F.et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:2002;603-616.
54. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
55. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di Lucia P., Lang R.et al. Inhibition of IL-12 production by 1,25-dihydroxyVitamin D3. Involvement of NF-κB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101:1998;252-262.
56. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A.et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185:1997;1743-1751.
57. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84-89.
58. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A.et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:1998;3096-3100.
59. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F.et al. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:2002;237-243.
60. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R.et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11:2003;245-258.
61. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A.et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:1999;919-923.
62. Penna G., Sozzani S., Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167:2001;1862-1866.
63. Penna G., Roncari A., Colonna M., Adorini L. 1,25 dihydroxyvitamin D3 upregulates the expression of the inhibitory receptor ILT3 on dendritic cells. Minerva. Biotech. 14:2002;71.
64. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195:2002;695-704.
65. Xing N., Raje L.M., Bachman L.A., McKean D.J., Kumar R., Griffin M.D. Distinctive dendritic cell modulation by Vitamin D(3) and glucocorticoid pathways. Biochem. Biophys. Res. Commun. 297:2002;645-652.
66. Tajima K., Amakawa R., Ito T., Miyaji M., Takebayashi M., Fukuhara S. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. Immunology. 108:2003;321-328.